Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autophagy Deregulation in HIV-1-Infected Cells Increases Extracellular Vesicle Release and Contributes to TLR3 Activation.

Viruses·2024
Same author

A New Structural Model of Apolipoprotein B100 Based on Computational Modeling and Cross Linking.

International journal of molecular sciences·2022
Same author

Predictive Models to Identify Small Molecule Activators and Inhibitors of Opioid Receptors.

Journal of chemical information and modeling·2021
Same author

Rescue of codon-pair deoptimized respiratory syncytial virus by the emergence of genomes with very large internal deletions that complemented replication.

Proceedings of the National Academy of Sciences of the United States of America·2021
Same journal

Correction: Bulatov et al. Camelpox Virus in Western Kazakhstan: Assessment of the Role of Local Fauna as Reservoirs of Infection. <i>Viruses</i> 2024, <i>16</i>, 1626.

Viruses·2026
Same journal

Correction: Franco et al. Whole Blood Volume-Based Absolute Quantification of HTLV-1 Proviral Load: A Comparative Method Evaluation Study. <i>Viruses</i> 2026, <i>18</i>, 580.

Viruses·2026
Same journal

Correction: Medkour et al. Adenovirus Infections in African Humans and Wild Non-Human Primates: Great Diversity and Cross-Species Transmission. <i>Viruses</i> 2020, <i>12</i>, 657.

Viruses·2026
Same journal

Burden of Malaria and Dengue Across Global, Asian, and Chinese Populations Based on GBD 2021 Data: A Quantitative Assessment of Importation Risks to China.

Viruses·2026
Same journal

First Report of <i>Orthonairovirus songlingense</i> in <i>Haemaphysalis concinna</i> Ticks from Russia.

Viruses·2026
Same journal

Epidemiological and Virological Characteristics of H9N2 Avian Influenza Virus in Jiangsu Province, China, 2024.

Viruses·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Respiratory Syncytial Virus Vaccine Design Using Structure-Based Machine-Learning Models.

Thomas C McCarty1, Iosif I Vaisman2

  • 1RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Viruses
|June 27, 2024
PubMed
Summary
This summary is machine-generated.

Researchers used computational methods to identify mutations in respiratory syncytial virus (RSV) nonstructural protein 1 (NS1) for vaccine development. These mutations reduced viral replication and enhanced host immune responses, paving the way for safer live-attenuated RSV vaccines.

Keywords:
NS1computational analysis of viral protein structurecomputational mutagenesisinterferon antagonistlive-attenuated virus vaccine designmachine learningmutational analysis of interferon antagonistnegative-strand RNA virusnonstructural protein 1respiratory syncytial virusviral protein structure modification

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.6K
Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
09:08

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on: July 27, 2021

3.7K

Related Experiment Videos

Last Updated: Jun 10, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.6K
Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
09:08

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on: July 27, 2021

3.7K

Area of Science:

  • Virology
  • Vaccine Development
  • Structural Biology

Background:

  • Live-attenuated vaccines for respiratory syncytial virus (RSV) require mutations that reduce viral replication while maintaining immunogenicity.
  • Current methods for identifying attenuating mutations include biologic selection and reverse-genetic manipulation.
  • Balancing reduced replication and antigen expression is crucial for effective live-attenuated vaccine candidates.

Purpose of the Study:

  • To explore a novel computational approach for discovering attenuating mutations in RSV.
  • To identify specific amino acid substitutions in the RSV nonstructural protein 1 (NS1) that perturb its structure and function.
  • To evaluate the impact of these mutations on viral replication and host immune responses.

Main Methods:

  • Utilized protein structure modeling and machine learning to predict destabilizing amino acid substitutions in RSV NS1.
  • Introduced twelve predicted mutations into infectious RSV.
  • Analyzed mutant viruses in cell culture for effects on viral gene expression, host interferon and cytokine production, and apoptosis.

Main Results:

  • Structure-based prediction successfully identified mutations leading to varying degrees of NS1 functional loss.
  • Mutant viruses exhibited reduced multi-cycle replication in interferon-competent cells.
  • Observed decreased viral mRNA and protein expression, alongside increased interferon and apoptosis responses.

Conclusions:

  • Computational prediction of NS1 structural instability is a viable strategy for discovering attenuating mutations.
  • Identified mutations reduce viral replication and enhance host antiviral and apoptotic responses, key attributes for live-attenuated vaccine development.
  • This structure-based approach offers a promising avenue for generating safer and more effective RSV vaccine candidates.